Features
The Complex World of Heart-Lung Block Transplants
Stanford Health Care’s Department of Cardiothoracic Surgery completed ten heart-lung block transplants in 2018 – more than any other group in the world.
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Get the iPhone MyHealth app »
Get the Android MyHealth app »
The Stanford Heart Transplant Program has the accumulated wisdom of more than fifty years of research and patient care experience.
Our doctors and scientists work, collaboratively, to develop many innovations and continue to advance new techniques in transplant surgery.
Stanford is recognized worldwide as a pioneering center for heart transplants. Dr. Norman Shumway and his colleagues developed the experimental basis for transplants in their early work, which then paved the way for the first adult heart transplant in the U.S. at Stanford in 1968. To date, our medical teams have performed more than 1,200 heart transplants.
Our multidisciplinary program includes:
Innovations introduced in the transplant field from Stanford include:
Approximately 40 to 50 patients undergo heart transplantation each year at Stanford. The procedures are performed in patients from newborns to adults over 60 years of age. Almost every type of end-stage heart disease has been treated here, and the Stanford team remains a leader in introducing new concepts and treatments to improve outcomes for transplant patients.
Stanford Health Care’s Department of Cardiothoracic Surgery completed ten heart-lung block transplants in 2018 – more than any other group in the world.
Watch Jeffery Teuteberg, MD, associate professor and chief of heart failure, cardiac transplantations, and mechanical circulatory support for Stanford Health Care, discuss heart failure in our Heart Health Series.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Your doctor may request an evaluation by a heart failure specialist, who will review your medical records and determine if additional tests are necessary.
Patients being considered for a heart transplant will be referred to the Cardiomyopathy Center.
Self-referrals are accepted.
Bring results from prior lab tests, if requested.
Reach a transplant nurse coordinator at 650-498-9909.
For detailed information about what to expect before, during and after your heart transplant, please review the Patient Resource Guide.
International Patients
Phone: +1 650-723-8561
Email: IMS@stanfordhealthcare.org